Scienture Holdings, Inc.
SCNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001382574
No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Scienture Holdings, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 6 | 9 | +3 |
| Shares | 2.65K | 78.6K | +75.9K (+2,870.3%) |
| Value | $14.5K | $805.3K | +$790.7K (+5,436.0%) |
New holders (6)
Institutions that held Scienture Holdings, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 33,382 | $342.0K | 0.00% |
| Vanguard Group Inc | 14,548 | $149.0K | 0.00% |
| Virtu Financial LLC | 10,617 | $109.0K | 0.01% |
| Geode Capital Management, LLC | 10,198 | $104.4K | 0.00% |
| BlackRock Inc. | 8,220 | $84.2K | 0.00% |
| UBS Group AG | 246 | $2.52K | 0.00% |
Sold out (3)
Institutions that held Scienture Holdings, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Qube Research & Technologies Ltd | 100 | $520 |
| Bank of America Corp | 15 | $78 |
| Royal Bank of Canada | 67 | $0 |